Cargando…

Association Between Asymptomatic Proximal Deep Vein Thrombosis and Mortality in Acutely Ill Medical Patients

BACKGROUND: Asymptomatic proximal deep vein thrombosis (DVT) is an end point frequently used to evaluate the efficacy of anticoagulant thromboprophylaxis in medical patients. Recently, the clinical relevance of asymptomatic DVT has been challenged. METHODS AND RESULTS: The objective of this study wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raskob, Gary E., Spyropoulos, Alex C., Cohen, Alexander T., Weitz, Jeffrey I., Ageno, Walter, De Sanctis, Yoriko, Lu, Wentao, Xu, Jianfeng, Albanese, John, Sugarmann, Chiara, Weber, Traci, Lipardi, Concetta, Spiro, Theodore E., Barnathan, Elliot S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174250/ https://www.ncbi.nlm.nih.gov/pubmed/33586478 http://dx.doi.org/10.1161/JAHA.120.019459

Ejemplares similares

Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study
por: Spyropoulos, Alex C., et al.
Publicado: (2019)

Modified IMPROVE VTE Risk Score and Elevated D-Dimer Identify a High Venous Thromboembolism Risk in Acutely Ill Medical Population for Extended Thromboprophylaxis
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis
por: Lipardi, Concetta, et al.
Publicado: (2021)

Extended Thromboprophylaxis in Hospitalized Patients with Heart Failure: A Post Hoc Analysis of the MAGELLAN Study
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Benefit–Risk Assessment of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness
por: Raskob, Gary E., et al.
Publicado: (2022)

Benefit–Risk of Rivaroxaban for Extended Thromboprophylaxis After Hospitalization for Medical Illness: Pooled Analysis From MAGELLAN and MARINER
por: Raskob, Gary E., et al.
Publicado: (2021)

Post-Discharge Prophylaxis With Rivaroxaban Reduces Fatal and Major Thromboembolic Events in Medically Ill Patients
por: Spyropoulos, Alex C., et al.
Publicado: (2020)

Rivaroxaban Plus Aspirin for Extended Thromboprophylaxis in Acutely Ill Medical Patients: Insights from the MARINER Trial
por: Spyropoulos, Alex C., et al.
Publicado: (2022)

Rationale and design for the study of rivaroxaban to reduce thrombotic events, hospitalization and death in outpatients with COVID-19: The PREVENT-HD study
por: Capell, Warren H., et al.
Publicado: (2021)

Hospital-based use of thromboprophylaxis in patients with COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2020)

Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older
por: Ageno, Walter, et al.
Publicado: (2021)

Rivaroxaban for Prevention of Thrombotic Events, Hospitalization, and Death in Outpatients With COVID-19: A Randomized Clinical Trial
por: Piazza, Gregory, et al.
Publicado: (2023)

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA
por: Ageno, Walter, et al.
Publicado: (2019)

The Prevalence of Concomitant Deep Vein Thrombosis, Symptomatic or Asymptomatic, Proximal or Distal, in Patients With Symptomatic Pulmonary Embolism
por: Hirmerova, Jana, et al.
Publicado: (2018)

Cerebral and Splanchnic Vein Thrombosis: Advances, Challenges, and Unanswered Questions
por: Riva, Nicoletta, et al.
Publicado: (2020)

Splanchnic Vein Thrombosis: Current Perspectives
por: Valeriani, Emanuele, et al.
Publicado: (2019)

Controversies in the management of proximal deep vein thrombosis
por: Moss, Jana‐Lee, et al.
Publicado: (2022)

Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023)

Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival
por: Gary, T, et al.
Publicado: (2012)

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment
por: Senzolo, Marco, et al.
Publicado: (2019)

Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey
por: Riva, Nicoletta, et al.
Publicado: (2020)

Impact of World Thrombosis Day campaign
por: Wendelboe, Aaron M., et al.
Publicado: (2017)

Isolated proximal greater saphenous vein thrombosis and the risk of propagation to deep vein thrombosis and pulmonary embolism
por: Kim, Samuel H, et al.
Publicado: (2018)

Editorial: Endovascular treatment for acute proximal deep vein thrombosis
por: Yamada, Norikazu
Publicado: (2015)

Asymptomatic Deep Vein Thrombosis in a Patient with Major Depressive Disorder
por: Ishida, Takuto, et al.
Publicado: (2012)

Potential Association between Distal Deep Vein Thrombosis and Asymptomatic Atherosclerosis
por: Adamo, Angelo, et al.
Publicado: (2021)

Proximal aortic repair in asymptomatic patients
por: Carlestål, Emelie, et al.
Publicado: (2021)

High fibrinogen and mixed proximal and distal thrombosis are associated with the risk of residual venous thrombosis in patients with posttraumatic deep vein thrombosis
por: Liu, Yating, et al.
Publicado: (2023)

Prevalence and incidence of proximal deep vein thrombosis in critically ill patients
por: Panitchote, A, et al.
Publicado: (2010)

Prevalence of proximal deep vein thrombosis in hospitalized COVID-19 patients
por: Reichert, Guillaume, et al.
Publicado: (2021)

Incidence of proximal deep vein thrombosis in medical critical care patients
por: Permpikul, Chairat, et al.
Publicado: (2022)

Asymptomatic Isolated Calf Deep Vein Thrombosis: Does It Worsen after Varicose Vein Surgery?
por: Horiguchi, Sadaaki, et al.
Publicado: (2017)

Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction
por: Wang, Tzu-Fei, et al.
Publicado: (2023)

Asymptomatic Essential Thrombocytosis Presenting with Extrahepatic Portal Vein Thrombosis: A Case Report
por: Yakami, Yoshikazu, et al.
Publicado: (2023)

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
por: Senzolo, Marco, et al.
Publicado: (2018)

The Importance of Symptomatic or Asymptomatic Transcatheter Heart Valve Thrombosis
por: Seropian, Ignacio M.
Publicado: (2021)

MASSIVE BIVENTRICULAR THROMBOSIS IN ASYMPTOMATIC CORONAVIRUS-2019 INFECTION
por: Taha, Israa, et al.
Publicado: (2022)

Association Between Inferior Vena Cava-Involved Thrombosis, Severe Iliac Vein Stenosis, and Proximal Pulmonary Embolism in Patients With Deep Vein Thrombosis
por: Gong, Maofeng, et al.
Publicado: (2023)

Upper Extremity Deep Vein Thrombosis and Asymptomatic Vein Occlusion in Patients With Transvenous Leads: A Systematic Review and Meta-Analysis
por: Duijzer, Daniël, et al.
Publicado: (2021)

Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels()
por: Demelo-Rodríguez, P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_417qtn7bfestqda9voe9v8anec